These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 14437052)

  • 1. Clinical studies of propionyl erythromycin lauryl sulfate in children.
    REICHELDERFER TE; BAIRD RL; OSSOFSKY HJ
    Antibiot Annu; 1959-1960; 7():899-903. PubMed ID: 14437052
    [No Abstract]   [Full Text] [Related]  

  • 2. Propionyl erythromycin lauryl sulfate in the treatment of pediatric infections.
    WEIHL C
    J Obstet Gynaecol Br Emp; 1961; 1():28-34. PubMed ID: 13783817
    [No Abstract]   [Full Text] [Related]  

  • 3. The ratio of antimicrobial activity between propionyl erythromycin lauryl sulfate and erythromycin ethyl carbonate.
    GRIFFITH RS
    Antibiot Chemother (Northfield); 1961 Sep; 11():555-9. PubMed ID: 13901862
    [No Abstract]   [Full Text] [Related]  

  • 4. Propionyl erythromycin ester lauryl sulfate in the treatment of treponematosis and chancroid.
    CORDERO FA
    Antibiot Chemother (Northfield); 1961 Dec; 11():764-71. PubMed ID: 13881298
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of the blood levels obtained with 2 new esters of erythromycin: propionyl erythromycin and propionyl erythromycin lauryl sulfate].
    VIALLIER J; OLLAGNIER C; RONDELET J; AUGAGNEUP J
    Therapie; 1961; 16():878-95. PubMed ID: 13925737
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on propionyl erythromycin lauryl sulfate (PELS)].
    KATO Y; SAITO A; NAKAYAMA I; CHIBA A; TOMIZAWA M; SHIBAKI H
    J Antibiot B; 1962 Oct; 15():300-2. PubMed ID: 14042115
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical use of propionyl erythromycin lauryl sulfate].
    TACHIBANA K; ODA S; UEO H
    Hifuka Kiyo; 1961 Sep; 56():259-65. PubMed ID: 13918855
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatosensitization caused by propionyl erythromycin lauryl sulfate.
    GUEVIN R; TEN PAS A
    Henry Ford Hosp Med Bull; 1963 Mar; 11():77-81. PubMed ID: 13951167
    [No Abstract]   [Full Text] [Related]  

  • 9. Further pharmacological studies on propionyl erythromycin ester lauryl sulfate.
    LEE CC; ANDERSON RC; STEPHENS VC
    Antibiot Chemother (Northfield); 1961 Feb; 11():110-7. PubMed ID: 13760219
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of propionyl erythromycin lauryl sulfate (S6003)].
    AZUMA I; ABE K; SEO F; KAWAGUCHI S
    Nihon Ganka Kiyo; 1961 Jul; 12():658-64. PubMed ID: 13863582
    [No Abstract]   [Full Text] [Related]  

  • 11. Erythromycin propionate: a clinical and laboratory study.
    SALITSKY S; GEIGER JK; MELLMAN WJ; FOLTZ EL
    Antibiot Annu; 1959-1960; 7():893-8. PubMed ID: 14441020
    [No Abstract]   [Full Text] [Related]  

  • 12. [SUCESSFUL TREATMENT OF PYODERMA WITH PROPIONYL ERYTHROMYCIN LAURYL SULFATE].
    ABE T; KATO T; SUGANO H
    Hifuka Kiyo; 1963 Jan; 58():53-7. PubMed ID: 14045191
    [No Abstract]   [Full Text] [Related]  

  • 13. Lauryl sulfate salt of propionyl erythromycin: antibacterial activity in serum and therapeutic evaluation of low doses.
    LIMSON BM
    Antibiot Chemother (Northfield); 1961 Oct; 11():630-6. PubMed ID: 14465340
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of antibacterial activity in the sera of subjects ingesting propionyl erythromycin lauryl sulfate and erythromycin ethyl carbonate.
    GRIFFITH RS
    Antibiotic Med Clin Ther (New York); 1960 May; 7():320-6. PubMed ID: 13851768
    [No Abstract]   [Full Text] [Related]  

  • 15. [CASE OF HYPERSENSITIVE HEPATITIS DUE TO PROPIONYL ERYTHROMYCIN LAURYL SULFATE].
    FUKAYA K; TOMORI G
    Naika; 1964 Sep; 14():741-4. PubMed ID: 14202924
    [No Abstract]   [Full Text] [Related]  

  • 16. Allergic hepatitis caused by propionyl erythromycin ester of lauryl sulfate.
    JOHNSON DF; HALL WH
    N Engl J Med; 1961 Dec; 265():1200-2. PubMed ID: 14452017
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacology and toxicology of propionyl erythromycin ester lauryl sulfate.
    ANDERSON RC; LEE CC; WORTH HM; HARRIS PN
    J Am Pharm Assoc Am Pharm Assoc; 1959 Nov; 48():623-8. PubMed ID: 13848813
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolism of propionyl erythromycin lauryl sulfate. II. Fate of the lauryl sulfate moiety in the rat and man.
    Murphy PJ; Williams TL; McMahon RE; Crabtree RE; Ridolfo AS
    Drug Metab Dispos; 1975; 3(3):164-70. PubMed ID: 238815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of erythromycin. Laboratory and clinical studies on propionyl erythromycin.
    LIMSON BM; ARAGON PR
    Acta Med Philipp; 1959; 16():1-22. PubMed ID: 13762201
    [No Abstract]   [Full Text] [Related]  

  • 20. [The problem of peroral application of erythromycin in infants].
    PEYCHL L
    Cesk Pediatr; 1961 Nov; 16():1000-3. PubMed ID: 14486066
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.